[go: up one dir, main page]

AU2002212555A1 - Yeast derived vaccine against ipnv - Google Patents

Yeast derived vaccine against ipnv

Info

Publication number
AU2002212555A1
AU2002212555A1 AU2002212555A AU1255502A AU2002212555A1 AU 2002212555 A1 AU2002212555 A1 AU 2002212555A1 AU 2002212555 A AU2002212555 A AU 2002212555A AU 1255502 A AU1255502 A AU 1255502A AU 2002212555 A1 AU2002212555 A1 AU 2002212555A1
Authority
AU
Australia
Prior art keywords
vaccines
ipnv
vaccine
polypeptide
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212555A
Inventor
Suzanne Breeman
Marie Beagley Labus
William Thomas Melvin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Aberdeen
Original Assignee
University of Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0027644A external-priority patent/GB0027644D0/en
Priority claimed from GB0030765A external-priority patent/GB0030765D0/en
Application filed by University of Aberdeen filed Critical University of Aberdeen
Publication of AU2002212555A1 publication Critical patent/AU2002212555A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Disclosed are processes for producing a vaccine for use against infectious pancreatic necrosis virus (IPNV) in fish, which process comprises culturing a yeast host cell which expresses, and preferably secretes, an IPNV polypeptide, and formulating the polypeptide as a vaccine (preferably by using, or partially purifying) the supernatant. Such vaccines have advantages over vaccines produced in bacteria. Also disclosed are vaccines based VP3 and VP2var proteins, optionally in combination with antigens protective against other fish diseases. The invention further provides related materials (e.g. primers, vectors and host cells) and methods and uses of the vaccines for prophylaxis and therapy.
AU2002212555A 2000-11-11 2001-11-12 Yeast derived vaccine against ipnv Abandoned AU2002212555A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0027644A GB0027644D0 (en) 2000-11-11 2000-11-11 Fish vaccine
GB0027644 2000-11-11
GB0030765 2000-12-14
GB0030765A GB0030765D0 (en) 2000-12-14 2000-12-14 Fish vaccine
PCT/GB2001/004986 WO2002038770A1 (en) 2000-11-11 2001-11-12 Yeast derived vaccine against ipnv

Publications (1)

Publication Number Publication Date
AU2002212555A1 true AU2002212555A1 (en) 2002-05-21

Family

ID=26245278

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212555A Abandoned AU2002212555A1 (en) 2000-11-11 2001-11-12 Yeast derived vaccine against ipnv

Country Status (8)

Country Link
EP (1) EP1334197B1 (en)
AT (1) ATE494377T1 (en)
AU (1) AU2002212555A1 (en)
CA (1) CA2428027C (en)
DE (1) DE60143810D1 (en)
DK (1) DK1334197T3 (en)
NO (1) NO333007B1 (en)
WO (1) WO2002038770A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2442004A1 (en) * 2001-03-23 2002-10-03 David J. Kyle Microbial feeds for aquaculture and agriculture
US7317142B2 (en) 2002-12-13 2008-01-08 Prodi Gene, Inc. Immunization of fish with plant-expressed recombinant proteins
AU2004279610B2 (en) 2003-10-07 2010-02-25 Ingrid Dheur Piscirickettsia salmonis antigens and use thereof
WO2006037383A1 (en) * 2004-10-01 2006-04-13 Michel Thiry Piscirickettsia salmonis antigens and use thereof
WO2008140610A2 (en) 2006-12-20 2008-11-20 Advanced Bionutrition Corporation Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast
US8753878B2 (en) * 2006-12-22 2014-06-17 Ewos S.A. Process and formulation for immunizing fish in aquaculture systems
EP2231698B9 (en) 2007-12-19 2014-10-29 Intervet International BV Vaccine antigens from piscirickettsia salmonis
CA2885333C (en) 2012-09-26 2021-02-09 Fvg Limited Subunit immersion vaccines for fish
CN110573604A (en) * 2017-02-28 2019-12-13 非营利性组织佛兰芒综合大学生物技术研究所 Tools and methods for oral protein delivery
CN115804837B (en) * 2022-02-24 2023-06-20 中国水产科学研究院黑龙江水产研究所 A kind of infectious pancreatic necrosis adjuvant vaccine and its preparation method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165925A (en) * 1989-05-02 1992-11-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Vaccine for immunizing fish against infectious pancreatic necrosis virus

Also Published As

Publication number Publication date
DE60143810D1 (en) 2011-02-17
EP1334197B1 (en) 2011-01-05
WO2002038770A1 (en) 2002-05-16
CA2428027A1 (en) 2002-05-16
CA2428027C (en) 2012-09-11
NO20032097D0 (en) 2003-05-09
DK1334197T3 (en) 2011-04-04
NO333007B1 (en) 2013-02-18
EP1334197A1 (en) 2003-08-13
NO20032097L (en) 2003-07-10
ATE494377T1 (en) 2011-01-15

Similar Documents

Publication Publication Date Title
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
WO2007024941A3 (en) Polyvalent vaccine
MXPA05009096A (en) Animal-free cell culture method.
SI1951296T2 (en) Cell-derived viral vaccines with low levels of residual cell dna by betapropiolactone
WO2003024480A3 (en) In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
NZ589755A (en) Vaccine composition useful for hpv and hepatitis b infections and a method for preparing the same
AU2785089A (en) Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus
WO2006031264A3 (en) Siv and hiv vaccination using rhcmv- and hcmv-based vaccine vectors
UY25146A1 (en) HPV FUSION PROTEINS INCLUDING AN E6, E7 OR E6E7 PROTEIN FUSED WITH A HAEMOPHILUS INFLUENZAE B PROTEIN D OR DERIVED FROM THEM AND COMPOSITIONS FOR USE AS VACCINES THAT INCLUDE THEM
EP1054683A4 (en) ANTIGENIC PEPTIDE COMPLEX / MODIFIED STRESS PROTEIN
WO2003082183A3 (en) Protein-based streptococcus pneumoniae vaccines
CA2505942A1 (en) West nile virus vaccine
AU2002212555A1 (en) Yeast derived vaccine against ipnv
WO2008097267A3 (en) Vaccines against vesicular stomatitis
Stuart et al. Cassette-based presentation of SIV epitopes with recombinant gas vesicles from halophilic archaea
DE60218327D1 (en) INACTIVATED IMMUNOGENIC BACTERIAL ALL-CELL COMPOSITIONS
WO2000050074A3 (en) Neisserial vaccine compositions and methods
AU2003288510A1 (en) Immunizing fish against viral infection
WO2009141434A4 (en) Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant
AU4149699A (en) Use of inactivated immunosuppressive and/or angiogenic immunogenic proteins, preparation method and pharmaceutical or vaccine uses
WO2005115448A3 (en) Multi plasmid system for the production of influenza virus
IL148741A0 (en) Vaccine
WO2004054508A3 (en) Immunogenic compositions including rough phenotype brucella host strains and complementation dna fragments
AU5573196A (en) A pluripotent vaccine against enveloped viruses
WO2002088338A3 (en) Method for replicating the hepatitis c virus